| Source HCPCS Code |
|
Target NDC Code |
J2182
Injection, mepolizumab, 1mg
|
⇄
|
00173-0881-01
NUCALA 100 MG VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2017 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
EA |
|
|
|
J2182
Injection, mepolizumab, 1mg
|
⇄
|
00173-0892-01
NUCALA 100 MG/ML AUTO-INJEC
|
| Detail Information |
| Relationship Start Date |
06/17/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
J2182
Injection, mepolizumab, 1mg
|
⇄
|
00173-0892-42
NUCALA 100 MG/ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
06/17/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
J2182
Injection, mepolizumab, 1mg
|
⇄
|
00173-0904-42
NUCALA 40 MG/0.4 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
06/27/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
J2182
Injection, mepolizumab, 1mg
|
⇄
|
00173-0881-01
NUCALA
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|